Health Check: UBS turns ultra-bullish on Aussie healthcare leaders
Bell Potter says Monash IVF has fertile recovery prospects
Telix wins FDA usage expansion for prostate cancer imaging
Financial giant UBS has declared that enough is enough with lagging healthcare valuations – and now believes it will be the best performer of any ASX sector.
In bestowing 'pet sector' status, the firm says that healthcare stocks are the cheapest they have been in 10 years.
This follows three years of remorseless earnings per share (EPS) downgrades.
The firm opines healthcare now offers the best EPS growth of all ASX sectors, with an expected increment of almost 20% in the 2025-26 year.
The S&P/ASX 200 healthcare index has fallen 5% over the past 12 months and is down 7% year to date.
In contrast, the broader ASX200 index looks to be finishing the year around 9% higher.
'Investor sentiment towards the healthcare sector has broadly cooled over the last year, with some marked deterioration seen across many stocks,' UBS says.
' Cochlear (ASX:COH) in particular has seen investor apathy build over the last year, which represents a significant change of views versus .'
The firm has upgraded Cochlear to a 'buy' for the first time since 2011.
'Challenging market conditions'
Meanwhile, Bell Potter notes that 'challenging market conditions' have mostly persisted for small and mid-cap healthcare stocks.
Of the 35 stocks the firm covers, only nine are trading at a premium to their December-end values.
'The macro factors driving this broader performance include the uncertainty arising from leadership changes at the US Food and Drug Administration (FDA) and proposals to lower prescription drug price in the US,' the firm says.
'Consequently, institutional investors have largely adopted a wait-and-see approach.'
However, Bell Potter expects new drug approvals and earnings growth 'to lead to a wave of new capital flowing into the sector'.
Oh baby! That's an interesting call
Bell Potter's three favourite healthcare stocks include the troubled Monash IVF Group (ASX:MVF), if only because the share price reaction to the company's embryo-woes looks excessive.
In the broker's half-year run-down of best buys across all sectors, the firm's other two healthcare picks are Telix – that name again – and Neuren Pharmaceuticals (ASX:NEU).
Monash IVF's two reported embryo transfer errors resulted in the June 12 resignation of CEO Michael Knaap.
Prominent silk Fiona McLeod is carrying out an independent probe into the snafus.
Meanwhile, Monash IVF shares have halved since January.
Bell Potter says Monash IVF trades on a multiple of six times. This compares with 12.5 times for nearest rival Virtus Health in 2022, when it was taken over by BGH Capital and delisted.
'The depressed share price may also invite a bid for the company adding corporate appeal to a deep value investment thesis.'
The firm reckons Monash IVF is worth $1.15 a share, more than twice its current valuation.
On safe ground
With Telix, Bell Potter says revenues from its lead prostate imaging product Illucix should continue to grow as it wins US market share.
The FDA recently approved another prostate imaging agent, Gozellix, and should green light the kidney cancer imaging product Zircaix in the September quarter.
Neuren is making hay from US sales of its Rett syndrome therapy Daybue, via partner Acadia.
But the firm believes the bigger value driver is Neuren's separate compound NNZ-2591. This is for the rare 'orphan' diseases Phelan-McDermid, Angelman, Pitt Hopkins and Prader-Willi syndromes.
NNZ-2591 is thought to be more effective and less toxic than Daybue – and the market could be bigger.
Neuren reported positive phase II trial results for Phelan-McDermid and expects to kick off a phase III study within months.
With $340 million of cash, Neuren has oodles of dosh to fund the 160-patient trial.
In fact, the company is undertaking a share buyback to soak up stock at discounted levels.
Bell Potter also rates Mesoblast Mesoblast (ASX:MSB), Clarity Pharmaceuticals (ASX:CU6), Immutep (ASX:IMM) and EBR Systems (ASX:EBR) as speculative buys.
Telix in FDA win
Back to Telix – yet again – the FDA has approved a label extension for Illucix.
This will enable doctors to patients for radioligand (targeted radiation) therapy earlier in the piece, before they progress to chemotherapy.
Telix estimates clinical use of Illuccix will increase by at least 20,000 scans annually.
The label expansion piggybacks the FDA's recent approval of an expanded indication for Novartis's Pluvicto radioligand therapy.
The firm says Telix's imaging has become a standard of care in prostate cancer detection and management.
The FDA also recently approved Telix's Gozellix, another prostate cancer imaging agent.
Cleo pops down to the (bio) bank
The US National Cancer Institute has granted ovarian cancer diagnostics developer Cleo Diagnostics (ASX:COV) access to a US cache of blood samples.
Collected from 155,000 cancer patients over the last decade, the repository is called the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) biobank.
Cleo says PLCO is a a gold-standard resource, having derived from one of the 'largest and most influential US longitudinal cancer studies'.
Cleo will use the data to strengthen its FDA marketing submission for a pre-surgical test and expects to complete the supporting trials by the end of the year.
Earlier, Cleo entered a compact with University College London to access a capacious ovarian cancer biobank.
'Together, these biobanks form a comprehensive, internationally representative ... population that Cleo will use to enhance its clinical evidence and substantially derisk key regulatory milestones,' Cleo CEO Richard Allman says.
Cleo's two trials pertain to pre-surgical identification and screening of an asymptomatic population.
Earlier studies showed Cleo's tool confirmed or ruled out tumours 95% of the time, thus outperforming standard-of-care assays.
Capital raising corner
At the smaller end of the sector, companies are raising enough to keep the lights on – and perhaps a little more.
The maker of asthma adherence devices that wrap around 'puffers', Adherium (ASX:ADR) plans to raise $4 million at half a cent apiece.
This is by way of an insto and retail offer, partly underwritten and struck at half a cent.
Investors also get one option for every share issued, as well as a 'piggyback' bonus option.
An existing holder Phillip Thematic Fund has its hands up for $800,000, while Phillip Asset Management and Trudell Medical are good for $1 million of underwriting.
Heart device play Cardiex (ASX:CDX) has raised about $4.1 million in a rights offer, having gathered $2.4 million in a placement.
Both were done at four cents a share.
TALi Digital (ASX:TD1) is seeking $1.48 million in a right issue, having mustered $800,000 in a private placement. Both were struck at one-tenth of a cent per share.
Tali is developing tools that test kids for conditions including autism and attention deficit hyperactivity disorder.
This month Tali acquired You Can Do It! Education, 'a social-emotional learning program aimed at improving the social, emotional, and academic outcomes of young people.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
34 minutes ago
- ABC News
Rate relief, food payments and water funding in new $75m Victorian drought package
The Victorian government has announced a $75 million drought assistance package for farmers struggling through the state's long dry spell. It is the biggest and most significant announcement the government has made during this drought and includes council rate relief for farmers, with a rebate of about 40 per cent for producers in 12 of the worst-affected areas of the south-west. The funding also includes $2 million for food and grocery support, with up to $1,000 per household, $6.3 million to cover government "red tape" fees and $25 million for water management. "We've been listening to farmers and communities who do it tough," Premier Jacinta Allan said. "This support delivers real help, right now." The state's peak farm lobby group, the Victorian Farmers Federation (VFF) welcomed the support but said it should have come earlier. "A lot of farmers will tell you [the drought support package] has come too late," VFF president Brett Hosking said. The government has now announced a total of $144 million for farmers during the extended dry conditions. The state's south-west has been worst affected with 15 months of record low or below-average rainfall until last month. Almost $36 million will go towards rate relief for farmers in the council areas of Ararat, Moyne, Colac Otway, Pyrenees, Corangamite, Southern Grampians, Glenelg, Surf Coast, Golden Plains, Warrnambool, City of Geelong and southern parts of West Wimmera. The government says that equates to a 40 per cent rate reduction. "This isn't about dollars, it's about backing the people who feed our state and the regional communities that keep our state strong." Ms Allan said. The government has also committed $24 million to water infrastructure to better prepare for droughts. It will be used to extend the East Grampians rural water pipeline and to expand emergency water supply options, groundwater bores and domestic water access. "We are investing in both short-term solutions and legacy infrastructure to improve resilience and water security for farmers and their communities," Agriculture Minister Ros Spence said. Despite recent rain, the state is still feeling the effects of drought, with a cold winter resulting in very little growth in pastures for hungry livestock. Ararat lamb producer Charlie de Fegely said the funding was surprising and welcome news. "This is fantastic, because people are desperate for water, given the very long dry spell," he said. Mr de Fegely said a secure water supply would enable farmers to retain livestock during drought. "Tragically, breeding ewes are being sold simply because people don't have water," he said. Mr Hosking said it would take time for farmers to recover. "There is no feed in the paddock, particularly for cattle and even for sheep there is not the feed to support them in the paddock, and farmers are still hand feeding," he said. The Country Women's Association (CWA) will manage the household payments of up to $1,000 for farmers in the south-west. Catchment Management Authorities will receive $1 million to run drought employment programs, which help people receive payments while working on projects that help the environment. There is also $6.3 million for fee and duty relief, which Brett Hosking said would help, although he had questions about the details. "It's removal of red tape funding on things like biosecurity levees that you pay on the sale of livestock will hopefully be waived and I think the government is still working out the details on that one," he said.
News.com.au
42 minutes ago
- News.com.au
Toorak: $30m+ health-boosting mansion sold to overseas-based buyer
Wealthy Hong Kong and Melbourne-based power couple Anita Wong and Wilson Lai have sold their award-winning Toorak mansion for more than $30m. It's the biggest St Georges Rd sale since a significant fire at a prominent mansion on the street last month. Ms Wong and Mr Lai's four-level house was advertised with a $36m-$39m asking range but the sales price is undisclosed. Mr Lai has previously served as wireless tech company Hollyland Group Holdings' president, while Ms Wong is an investment banking executive. Features of the impressive abode at 12 St Georges Rd include a wellness centre with a gym and sauna, pool, lift-up driveway into the six-car basement garage, nightclub-style area with a bar, 500-bottle wine cellar and gardens by famous landscape designer Paul Bangay. The six-bedroom property was the first Australian residential home to have a Healthy Living system installed from the US-based wellness real estate and technology firm Delos. It incorporates a water filtration and mechanical HEPA (High-Efficiency Particulate Air) air filtration installation system. Construction company Easton won the Master Builders Victoria residential Master Builder of the Year award in 2021 for their work on the mansion, designed by SJB architects' Andrew Parr. Marshall White's Marcus Chiminello and Sotheby's International Melbourne's Rob Curtain had the listing. Mr Curtain said the owners had designed the house to showcase their art collection. They were also heavily influenced by Feng Shui principles to boost resident's feelings of health and balance. 'Even the date and time of the campaign launch was influenced by Feng Shui and the date they will hand over the keys to the new owner too, even the final price,' Mr Curtain said. He declined to comment on the sold figure but confirmed the buyer was an overseas-based purchaser with business interests in Australia. Mr Curtain said the mansion attracted strong interest from interstate and overseas, with one buyer flying in from Sydney to inspect it. He added that the recent St Georges Rd fire had no impact on the sales campaign. Mr Chiminello said that all parties were thrilled with the outcome of the sale.
ABC News
an hour ago
- ABC News
Brisbane Star Entertainment casino workers to strike over pay negotiations amid ongoing financial woes
Hundreds of workers at Star's Brisbane casino are set to walk off the job, saying the entertainment group has proposed cutting penalty rates as it faces financial woes. United Workers Union president Jo Schofield said staff would take protected industrial action from 4pm to 6pm after Star failed to bring a "reasonable offer" to the bargaining table. "They have been forced into this position because of the failure of Star to recognise the cost-of-living pressures [workers] are under, but also the skills, commitment and loyalty workers have shown to the company during what has been an incredibly tumultuous time," she said. A spokesperson for The Star said they were "disappointed" workers were taking industrial action as it would impact visitors. "The Star has been doing everything possible to secure a stable financial future that will provide security for its workers, customers, suppliers, investors, and other stakeholders," they said. The spokesperson said The Star had been in "long and challenging" negotiations with unions in Brisbane. "We have been flexible, diligent, and measured in making an offer that adds wage growth for team members whilst absolutely stretching the financials of the business," they said. "We value all team members and offer excellent employee benefits. "We are disappointed that protected industrial action will be taken — as this action impacts all visitors that arrive to The Star Brisbane seeking memorable hospitality experiences." The future of the Brisbane casino has been in doubt for months with Star Entertainment's shares plummeting in February and the company failing to post its financial results in March. It entered into a deal with Hong Kong investors in early March, after months of warnings about its financial future. However, on Monday Hong Kong investors Chow Tai Fook Enterprises and Far East Consortium threatened to walk away from an agreement to buy Star's stake in the Queen's Wharf casino and hotel complex for $53 million. The two firms issued Star with a notice to terminate the deal, which will come into effect on Monday unless it is withdrawn within five business days. Last week, Star shareholders separately approved a $300 million rescue deal backed by US casino giant Bally's and existing investor Bruce Mathieson. Queensland Premier David Crisafulli said he was worried about Star's operations and would continue to support staff. "Whatever iteration it takes in the future, our only concern is that the doors stay open and that people can go to work during that transition of ownership or whatever that looks like," he said. "We just want workers to have a job."
